-
Live Biotherapeutics Drug Discovery
-
Next-Generation Probiotics (NGPs)
- Atopobium vaginae
- Anaerobutyricum soehngenii
- Anaerostipes spp.
- Akkermansia muciniphila
- Bacteroides spp.
- Blautia spp.
- Butyricicoccus pullicaecorum
- Bifidobacterium spp.
- Christensenella minuta
- Clostridium spp.
- Dysosmobacter welbionis
- Eggerthellaceae Family
- Enterococcus spp.
- Eubacterium hallii
- Escherichia coli
- Faecalibacterium prausnitzii
- Lactobacillus spp.
- Oxalobacter formigenes
- Parabacteroides spp.
- Propionibacterium freudenreichii
- Pediococcus pentosaceus
- Prevotella copri
- Roseburia spp.
- Ruminococcus spp.
- Salmonelle
- Streptococcus spp.
- Diseases Linked to NGPs
-
Next-Generation Probiotics (NGPs)
-
Services
-
Analytical Development and Qualification
- Monitoring Microbial Contaminants
- Specific Primers and Probes Design
- Microbial Isolation and Screening
- Functional Screening and Mechanism of Action
- Dissolution Testing and Drug Release Profiling
- QC Analytical Testing
- In-process Assay
- Final Product Assay
- Pre-formulation Capabilities Analysis
- Microbial Identification
- Biological Safety Test
- Potency Test
- Stability Test
- Gene Integration Stability Test
- Antibiotic Susceptibility/Resistance Test
- Monocyte Activation Test
- Determination of Bioburden
- Stress Response Profiling
- Carbohydrate Fermentative Profiles
- In Vitro Tests of Immune System Modulation
- Host-Microbe Interaction Tests
- Microbial Fermentation
- Microbial Purifying
- Microbial Stabilization
- Microbial Formulation
- Lab-scale Production
- Downstream Process Development
-
Analytical Development and Qualification
- Products
-
Technology
- Germ-free Mouse Model
- Design of Engineered Therapeutic Strains
- Tools for LBP Safety Assessment
- Cell-based In Vitro Assays
- Probiotic Enumeration
- Functional Profiling
- Collection Methods for Microbiome Samples
- In Vitro Gut Simulations
- Gut Microbiota Research
- Microbial Identification
- Antibiotic Susceptibility Testing
- Faecal Microbiota Transplants (FMT)
- Analysis of SCFAs
- Assessment of Potential Probiotic Properties
- Antimicrobial Assays
-
Support
-
Resources
- Understanding Probiotics: Characteristics and Applications
- Exploring Lactobacillus spp. for Drug Development and Probiotics
- What is the Relationship Between Probiotics and Human Health
- The Potential of Probiotics for Treating Foodborne Diseases
- The Potential of Probiotics in Neurodevelopmental Disorders
- Overview of Live Biotherapeutic Products
- Research and Development Status of Single-Strain LBPs
- Research and Development Status of Multi-Strain LBPs
- Engineered LBP for the Treatment of Metabolic Diseases
- Engineered LBP for the Treatment of Bacterial Infection
- Engineered LBP for the Treatment of IBD
- Challenges and Opportunities in Live Biotherapeutic Products Development
- The Relationship between Probiotics and the Immune System
- Discovery and Development Process of Live Biotherapeutics
- Host-LBP Interactions: Physiological Challenges
- Overcoming Physiological Challenges in LBP Discovery
- Overcoming Physiological Challenges in LBP Delivery
- Podcast
- Brochures
-
Resources
- Contact
